CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-01 | Barnes Alane P VP, General Counsel & Corp Sec | Shares withheld for taxes | −1,281 | $6.33 | $8K | 78,096 |
| 2017-01-01 | Babu Yarlagadda S Senior VP - Drug Discovery | Shares withheld for taxes | −1,639 | $6.33 | $10K | 109,789 |
| 2017-01-01 | Sheridan William P Senior VP - CMO | Shares withheld for taxes | −2,081 | $6.33 | $13K | 88,677 |
| 2017-01-01 | STAAB THOMAS R II Senior Vice President and CFO | Shares withheld for taxes | −1,676 | $6.33 | $11K | 122,511 |
| 2017-01-01 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −8,595 | $6.33 | $54K | 655,990 |
| 2016-12-19 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +3,250 | $3.78 | $12K | 127,437 |
| 2016-12-19 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,250 | $7.45 | $24K | 124,187 |
| 2016-12-19 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion · Emp. Stock Option (Right to Buy) | −3,250 | 96,010 | ||
| 2016-12-01 | INGRAM ROBERT ALEXANDER Director | Grant or award | +1,788 | $5.59 | $10K | 4,221 |
| 2016-12-01 | Hutson Nancy J Director | Grant or award | +1,788 | $5.59 | $10K | 28,664 |
| 2016-12-01 | Cohen Fred E Director | Grant or award | +1,788 | $5.59 | $10K | 115,867 |
| 2016-09-14 | Barnes Alane P VP, General Counsel & Corp Sec | Sale | −8,357 | $4.27 | $36K | 79,377 |
| 2016-09-01 | INGRAM ROBERT ALEXANDER Director | Grant or award | +2,433 | $4.11 | $10K | 2,433 |
| 2016-09-01 | Hutson Nancy J Director | Grant or award | +2,433 | $4.11 | $10K | 26,876 |
| 2016-09-01 | Cohen Fred E Director | Grant or award | +2,433 | $4.11 | $10K | 114,079 |
| 2016-08-25 | Babu Yarlagadda S Senior VP - Drug Discovery | Sale | −30,000 | $4.06 | $122K | 111,428 |
| 2016-08-16 | BAKER BROS. ADVISORS LP 10% owner | Sale | −140 | $4.29 | $600 | 1,551,387 |
| 2016-08-16 | BAKER BROS. ADVISORS LP 10% owner | Sale | −850 | $4.29 | $4K | 9,418,390 |
| 2016-08-15 | BAKER BROS. ADVISORS LP 10% owner | Sale | −56,417 | $4.83 | $272K | 1,551,527 |
| 2016-08-15 | BAKER BROS. ADVISORS LP 10% owner | Sale | −343,583 | $4.83 | $1.7M | 9,419,240 |
Page 42 of 45 · 882 trades